Cloning and functional studies of a splice variant of CYP26B1 expressed in vascular cells

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Elmabsout, Ali Ateia ^a   Kumawat, Ashok ^a   Saenz Méndez, Patricia ^b   Krivospitskaya, Olesya ^a   Sävenstrand, Helena ^a   Olofsson, Peder S ^c,d   Eriksson, Leif A ^e   Strid, Åke ^a   Valen, Guro ^f   Törmä, Hans ^g   Sirsjö, Allan ^a  

^a ÖREBRO UNIVERSITY   (Sweden)

^b UNIVERSIDAD DE LA REPÚBLICA   (Uruguay)

^c KAROLINSKA INSTITUTE   (Sweden)

^d FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^e UNIVERSITY OF GOTHENBURG   (Sweden)

^f UNIVERSITY OF OSLO   (Norway)

^g UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYTOCHROME P450; CYTOCHROME P450 26B1; RETINOIC ACID; UNCLASSIFIED DRUG; CYTOCHROME P 450 CYP26B1; CYTOCHROME P-450 CYP26B1; ISOPROTEIN;

AMINO ACID SEQUENCE; AORTA; ARTICLE; ATHEROSCLEROSIS; CATALYSIS; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYP26B1 GENE; DNA SYNTHESIS; ENDOTHELIUM CELL; ENZYME SPECIFICITY; EXON; GENE; GENE AMPLIFICATION; GENE EXPRESSION; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY ARTERY; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; SPLICEOSOME; STOMACH MUSCLE; VASCULAR SMOOTH MUSCLE; ANIMAL; CELL STRAIN COS1; CERCOPITHECUS; CHEMISTRY; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOLECULAR GENETICS; PATHOLOGY;

ATRA;

AMINO ACID SEQUENCE; ANIMALS; AORTA; ATHEROSCLEROSIS; CERCOPITHECUS AETHIOPS; CLONING, MOLECULAR; COS CELLS; CYTOCHROME P-450 ENZYME SYSTEM; EXONS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MOLECULAR SEQUENCE DATA; MUSCLE, SMOOTH, VASCULAR; PROTEIN ISOFORMS; TRETINOIN;

EID: 84861551190     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036839     Document Type: Article

References (28)

1. Colbert MC, (2002) Retinoids and cardiovascular developmental defects. Cardiovasc Toxicol 2: 25-39.
2. Streb JW, Miano JM, (2003) Retinoids: pleiotropic agents of therapy for vascular diseases. Curr Drug Targets Cardiovasc Haematol Disord 3: 31-57.
3. Rhee EJ, Nallamshetty S, Plutzky J, (2012) Retinoid metabolism and its effects on the vasculature. Biochim Biophys Acta 1821 230-40 pp. 230-40.
4. Krivospitskaya O, Elmabsout AA, Sundman E, Söderström LÅ, Ovchinnikova O, et al. (2012) A CYP26B1 polymorphism enhances retinoic acid catabolism which may aggravate atherosclerosis. Mol Med. In press.
5. Blomhoff R, Blomhoff HK, (2006) Overview of retinoid metabolism and function. J Neurobiol 66: 606-630.
6. Chen H, Howald WN, Juchau MR, (2000) Biosynthesis of all-trans-retinoic acid from all-trans-retinol: catalysis of all-trans-retinol oxidation by human P-450 cytochromes. Drug Metab Dispos 28: 315-22.
7. Marill J, Cresteil T, Lanotte M, Chabot GG, (2000) Identification of Human Cytochrome P450s Involved in the Formation of All-trans-Retinoic Acid Principal Metabolites Mol Pharmacol 58: 1341-8.
8. Pavez Loriè E, Li H, Vahlquist A, Törmä H, (2009) The involvement of cytochrome p450 (CYP) 26 in the retinoic acid metabolism of human epidermal keratinocytes. Biochim Biophys Acta 1791: 220-8.
9. White JA, Ramshaw H, Taimi M, Stangle W, Zhang A, et al. (2000) Identification of the human cytochrome P450, P450RAI-2, which is predominantly expressed in the adult cerebellum and is responsible for all-trans-retinoic acid metabolism. Proc Natl Acad Sci U S A 6: 6403-8.
10. Fujii H, Sato T, Kaneko S, Gotoh O, Fujii-Kuriyama Y, et al. (1997) Metabolic inactivation of retinoic acid by a novel P450 differentially expressed in developing mouse embryos. EMBO J 16: 4163-73.
11. Maden M, (2001) Role and distribution of retinoic acid during CNS development. Int Rev Cytol 209: 1-77.
12. White JA, Guo YD, Baetz K, Beckett-Jones B, Bonasoro J, et al. (1996) Identification of the retinoic acid-inducible all-trans-retinoic acid 4-hydroxylase. J Biol Chem 22: 29922-7.
13. Yamamoto Y, Zolfaghari R, Ross AC, (2000) Regulation of CYP26 (cytochrome P450RAI) mRNA expression and retinoic acid metabolism by retinoids and dietary vitamin A in liver of mice and rats. FASEB Journal 14: 2119-27.
14. Zolfaghari R, Cifelli CJ, Lieu SO, Chen Q, Li NQ, et al. (2007) Lipopolysaccharide opposes the induction of CYP26A1 and CYP26B1 gene expression by retinoic acid in the rat liver in vivo. Am J Physiol Gastrointest Liver Physiol 292: G1029-36.
15. Ross AC, Zolfaghari R, (2011) Cytochrome P450s in the Regulation of Cellular Retinoic Acid Metabolism. Annu Rev Nutr 31: 65-87.
16. Taimi M, Helvig C, Wisniewski J, Ramshaw H, White J, et al. (2004) A novel human cytochrome P450, CYP26C1, involved in metabolism of 9-cis and all-trans isomers of retinoic acid. J Biol Chem 2: 77-85.
17. Gallagher RE, (2002) Retinoic acid resistance in acute promyelocytic leukemia. Leukemia 16: 1940-58.
18. Kizaki M, Ueno H, Yamazoe Y, Shimada M, Takayama N, et al. (1996) Mechanisms of retinoid resistance in leukemic cells: possible role of cytochrome P450 and P-glycoprotein. Blood 87: 725-33.
19. Osanai M, Petkovich M, (2005) Expression of the retinoic acid-metabolizing enzyme CYP26A1 limits programmed cell death. Mol Pharmacol 67: 1808-17.
20. Pavez Loriè E, Cools M, Borgers M, Wouters L, Shroot B, et al. (2009) Topical treatment with CYP26 inhibitor talarozole (R115866) dose dependently alters the expression of retinoid-regulated genes in normal human epidermis. Br J Dermatol 160: 26-36.
21. Niederreither K, Abu-Abed S, Schuhbaur B, Petkovich M, Chambon P, et al. (2002) Genetic evidence that oxidative derivatives of retinoic acid are not involved in retinoid signaling during mouse development. Nat Genet 31: 84-8.
22. Otto DM, Henderson CJ, Carrie D, Davey M, Gundersen TE, et al. (2003) Identification of Novel Roles of the Cytochrome P450 System in Early Embryogenesis: Effects on Vasculogenesis and Retinoic Acid Homeostasis. Mol Cell Biol 23: 6103-16.
23. Abu-Abed S, Dollé P, Metzger D, Beckett B, Chambon P, et al. (2001) The retinoic acid-metabolizing enzyme, CYP26A1, is essential for normal hindbrain patterning, vertebral identity, and development of posterior structures. Genes Dev 15: 226-40.
24. Ocaya P, Gidlöf AC, Olofsson PS, Törmä H, Sirsjö A, (2007) CYP26 inhibitor R115866 increases retinoid signaling in intimal smooth muscle cells. Arterioscler Thromb Vasc Biol. 27: 1542-8.
25. Ocaya PA, Elmabsout AA, Olofsson PS, Törmä H, Gidlöf AC, et al. (2011) CYP26B1 plays a major role in the regulation of all-trans-Retinoic Acid metabolism and signaling in human aortic smooth muscle cells. J Vasc Res 48: 23-30.
26. Nelson DR, Koymans L, Kamataki T, Stegeman JJ, Feyereisen R, et al. (1996) P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 6: 1-42.
27. Olofsson P, Söderström L, Jern C, Sirsjö A, Ria M, et al. (2009) Genetic variants of TNFSF4 and risk for carotid artery disease and stroke. J Mol Med 87: 337-46.
28. Wågsäter D, Jatta K, Ocaya P, Dimberg J, Sirsjö A, (2006) Expression of IL-1β, IL-1 Receptor Type I and IL-1 Receptor Antagonist in Human Aortic Smooth Muscle Cells: Effects of all-trans-Retinoic Acid. J Vasc Res 43: 377-82.